Akers Biosciences Inc. (AKER)

[knuts4oe]

In most respects, leifsmith, I totally agree with you. But as to the FDA letter which removed anatabine from being available, they were correct that anatabine's professed ability to treat disease required that it achieve drug status as required by law. We were on our way with a phase 2 study to demonstrate that anatabine could impact Hashimoto's Thyroiditis when Rock Creek got itself into a funding disaster.